HMGCR and familial hypercholesterolemia: The main approach involved in hypercholesterolemia treatment is the suppression of cholesterol synthesis by declining of HMG-CoA reductase activity which is known as the rate-limiting enzyme in the cholesterol biosynthesis pathway [13].